AAAAAA
Results: 1-25/31
Authors:
LIST AF
HEATON R
GLINSMANNGIBSON B
CAPIZZI RL
Citation: Af. List et al., AMIFOSTINE STIMULATES FORMATION OF MULTIPOTENT AND ERYTHROID BONE-MARROW PROGENITORS, Leukemia, 12(10), 1998, pp. 1596-1602
Authors:
DOLL DC
KASPER LM
TAETLE R
LIST AF
Citation: Dc. Doll et al., TREATMENT WITH LOW-DOSE ORAL ETOPOSIDE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia research, 22(1), 1998, pp. 7-12
Authors:
LIST AF
Citation: Af. List, HEMATOPOIETIC STIMULATION BY AMIFOSTINE AND SODIUM PHENYLBUTYRATE - WHAT IS THE POTENTIAL IN MDS, Leukemia research, 22, 1998, pp. 7-11
Authors:
DODGE JE
LIST AF
FUTSCHER BW
Citation: Je. Dodge et al., SELECTIVE VARIEGATED METHYLATION OF THE P15 CPG ISLAND IN ACUTE MYELOID-LEUKEMIA, International journal of cancer, 78(5), 1998, pp. 561-567
Authors:
TAYLOR CW
WANG LM
LIST AF
FERNANDES D
PAINEMURRIETA GD
JOHNSON CS
CAPIZZI RL
Citation: Cw. Taylor et al., AMIFOSTINE PROTECTS NORMAL-TISSUES FROM PACLITAXEL TOXICITY WHILE CYTOTOXICITY AGAINST TUMOR-CELLS IS MAINTAINED, European journal of cancer, 33(10), 1997, pp. 1693-1698
Authors:
LIST AF
Citation: Af. List, NON-P-GLYCOPROTEIN DRUG EXPORT MECHANISMS OF MULTIDRUG-RESISTANCE, Seminars in hematology, 34(4), 1997, pp. 20-24
Authors:
LIST AF
BRASFIELD F
HEATON R
GLINSMANNGIBSON B
CROOK L
TAETLE R
CAPIZZI R
Citation: Af. List et al., STIMULATION OF HEMATOPOIESIS BY AMIFOSTINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME, Blood, 90(9), 1997, pp. 3364-3369
Authors:
STADHEIM C
HEATON R
GLINSMANNGIBSON B
GROGAN TM
LIST AF
Citation: C. Stadheim et al., IDARUBICIN SELECTION RESULTS IN MDR1-MEDIATED MULTIDRUG-RESISTANCE INTHE K562 HUMAN MYELOID-LEUKEMIA CELL-LINE, Blood, 90(10), 1997, pp. 3658-3658
Authors:
KLIMECKI W
HEATON R
GLINSMANNGIBSON B
LIST AF
Citation: W. Klimecki et al., AMIFOSTINE SUPPRESSES APOPTOSIS IN MYELODYSPLASTIC CD34-LIKE EFFECTS(CELLS AND PROMOTES PROGENITOR GROWTH VIA POLYAMINE), Blood, 90(10), 1997, pp. 2319-2319
Authors:
LIST AF
Citation: Af. List, ROLE OF MULTIDRUG-RESISTANCE AND ITS PHARMACOLOGICAL MODULATION IN ACUTE MYELOID-LEUKEMIA, Leukemia, 10(6), 1996, pp. 937-942
Authors:
LIST AF
Citation: Af. List, THE ROLE OF MULTIDRUG-RESISTANCE AND ITS PHARMACOLOGICAL MODULATION IN ACUTE MYELOID-LEUKEMIA, Leukemia, 10, 1996, pp. 46-51
Authors:
LIST AF
Citation: Af. List, THE ROLE OF MULTIDRUG-RESISTANCE AND ITS PHARMACOLOGICAL MODULATION IN ACUTE MYELOID-LEUKEMIA, Leukemia, 10, 1996, pp. 36-38
Authors:
SAMDANI A
VIJAPURKAR U
GRIMM MA
SPIER CS
GROGAN TM
GLINSMANNGIBSON BJ
LIST AF
Citation: A. Samdani et al., CYTOGENETICS AND P-GLYCOPROTEIN (PGP) ARE INDEPENDENT PREDICTORS OF TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA (AML), Leukemia research, 20(2), 1996, pp. 175-180
Authors:
LIST AF
HEATON R
GLINSMANNGIBSON B
CAPIZZI RL
Citation: Af. List et al., AMIFOSTINE PROTECTS PRIMITIVE HEMATOPOIETIC PROGENITORS AGAINST CHEMOTHERAPY CYTOTOXICITY, Seminars in oncology, 23(4), 1996, pp. 58-63
Authors:
LIST AF
KARANES C
DORR R
SPIER C
GROGAN T
GREER J
MOORE J
WEINBERGER J
SCHILLER G
DALTON W
PEARCE T
LITCHMAN M
Citation: Af. List et al., MODULATION OF ANTHRACYCLINE RESISTANCE IN POOR-RISK ACUTE MYELOID-LEUKEMIA (AML) WITH SDZ PSC-833 - RESULTS OF A PHASE I II MULTICENTER STUDY/, Blood, 88(10), 1996, pp. 1156-1156
Authors:
LIST AF
HEATON R
GLINSMANNGIBSON B
BRASFIELD F
CROOK L
CHARTRAND C
TAETLE R
KURMAN M
Citation: Af. List et al., AMIFOSTINE PROMOTES MULTILINEAGE HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) - RESULTS OF A PHASE I II CLINICAL-TRIAL/, Blood, 88(10), 1996, pp. 1802-1802
Authors:
LIST AF
SPIER CS
GROGAN TM
JOHNSON C
ROE DJ
GREER JP
WOLFF SN
BROXTERMAN HJ
SCHEFFER GL
SCHEPER RJ
DALTON WS
Citation: Af. List et al., OVEREXPRESSION OF THE MAJOR VAULT TRANSPORTER PROTEIN LUNG-RESISTANCEPROTEIN PREDICTS TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA, Blood, 87(6), 1996, pp. 2464-2469
Authors:
LIST AF
Citation: Af. List, INTERLEUKIN-3 - CLINICAL DEVELOPMENT OF A MULTIPOTENT CYTOKINE, Cancer research, therapy & control, 4(3), 1995, pp. 231-235
Authors:
KINTZEL PE
ROLLINS CJ
YEE WJ
LIST AF
Citation: Pe. Kintzel et al., LOW ITRACONAZOLE SERUM CONCENTRATIONS FOLLOWING ADMINISTRATION OF ITRACONAZOLE SUSPENSION TO CRITICALLY ILL ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS, The Annals of pharmacotherapy, 29(2), 1995, pp. 140-143
Authors:
LIST AF
HEATON R
GLINSMANNGIBSON B
SPEICHER L
CAPIZZI RL
Citation: Af. List et al., AMIFOSTINE STIMULATES HEMATOPOIETIC PROGENITORS FROM HUMAN NORMAL ANDMYELODYSPLASTIC (MDS) BONE MARROWS, European journal of cancer, 31A, 1995, pp. 245-245
Authors:
DOLL DC
GABRAIL NY
LIST AF
Citation: Dc. Doll et al., MYELOPROLIFERATIVE DISORDERS - INTRODUCTION, Seminars in oncology, 22(4), 1995, pp. 305-306
Authors:
LIST AF
HEATON R
GLINSMANNGIBSON B
CAPIZZI RL
Citation: Af. List et al., AMIFOSTINE IS A NOVEL STIMULANT OF BONE-MARROW PROGENITOR GROWTH IN MYELODYSPLASTIC SYNDROMES, Blood, 86(10), 1995, pp. 1327-1327
Authors:
LIST AF
CHAKOS H
GLINSMANNGIBSON B
BAMBERGER U
Citation: Af. List et al., REVERSAL OF CLASSICAL AND NON-PI-P-GLYCOPROTEIN (PGP) MEDIATED MULTIDRUG-RESISTANCE (MDR) BY BIBW22, Blood, 86(10), 1995, pp. 2052-2052
Authors:
GLINSMANNGIBSON B
SPIER C
BAIER M
TAETLE R
BROUDY VC
LIST AF
Citation: B. Glinsmanngibson et al., MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) RESTORES GROWTH OF MULTIPOTENTPROGENITORS IN MYELODYSPLASTIC SYNDROME, Leukemia, 8(5), 1994, pp. 827-832
Authors:
DORR RT
LIDDIL JD
IYENGAR BS
LIST AF
REMERS WA
Citation: Rt. Dorr et al., BIOLOGIC ACTIVITY OF A NUCLEOTIDE CONJUGATE BETWEEN MITOMYCIN-C AND CYTARABINE MONOPHOSPHATE, Nucleosides & nucleotides, 13(8), 1994, pp. 1655-1667